Vaxart (NASDAQ: VXRT) reported Q3 EPS of ($0.04), $0.03 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $72.4 million versus the consensus estimate of $21.15 million.

For earnings history and earnings-related data on Vaxart (VXRT) click here.